Table 3.

Safety profile (TEAE in >3 % of study subjects)^*

	Placebo	6:1-OM3	Total
	n = 54	n = 56	n = 110
Fishy burp	0 (0.0 %)	3 (5.4 %)	3 (2.7 %)
Flatulation	0 (0.0 %)	2 (3.6 %)	2 (1.8 %)
Nausea	3 (5.6 %)	2 (3.6 %)	5 (4.5 %)

^*Number (and percentage) of patients experiencing TEAE in each group during the course of the study. TEAE: Treatment-emergent adverse events